All News

Found 297 articles

• A Global Biopharmaceutical Development Service Organization Is Formed From Four Portfolio Companies: Averion International Corp., Trio Clinical Research, Fulcrum Pharma Developments Ltd. and ClinResearch/ADDPLAN

  9/10/2010

• Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories, Inc.

  5/5/2010

• Fulcrum Pharmaceuticals LLC Accepts 11.6 Million Stage Takeover Bid

  4/28/2010

• Syntaxin Announces Appointments of Chief Executive Officer, Chief Business Officer and Chief Development Officer

  2/2/2010

• Skyepharma PLC - Board Change - Chairman

  11/18/2009

• Centice Corporation Raises $6.1 Million

  10/22/2009

• Frank C. Condella, Jr. Elected to Columbia Laboratories, Inc.'s Board of Directors

  3/11/2009

• Fulcrum Pharma Announces New CEO

  4/1/2008

• Delcath Systems, Inc. Commences Mailing To Shareholders

  8/23/2006

• Delcath Systems, Inc. Issues Letter To Shareholders

  8/7/2006

• GTx, Inc. Announces The Appointment Of Dr. Michael Carter To Its Board Of Directors

  5/10/2006

• Biopheresis Technologies, Inc. Names Bernhard Ehmer Chief Executive Officer

  5/9/2006

• Senior Research And Development Executives Join Serenex

  11/16/2005

• icad, inc. Introduces PureLook(TM) Mammography Film Digitizer

  10/26/2005

• BioSpace Releases Its 3rd Edition Of Bio NC™

  1/27/2005

• Dr. Bruce McCreedy Appointment To Fulcrum Pharma plc Board

  1/6/2005

• French Sarcoma Group Release: New Study Finds Interruption Of Glivec (imatinib) In Patients Aith Advanced GIST Associated With High-Risk Of Re-Progression Within Following Year

  6/7/2004